Medicare Urged To Allow Home Infusion Plan With Direct Buying, Billing By Outside Providers

Manufacturers seek additional flexibility from Medicare to facilitate home infusions as surveys indicate patient visits to physician offices have dropped by 40% to 68% in recent weeks, signaling a decline in adherence for physician-administered drugs. 

Nurse putting woman on a drip
CMS Home Infusion Plan Too Cumbersome, Industry Says

More from Market Access

More from Pink Sheet